Filing Details
- Accession Number:
- 0001576885-24-000026
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2024-01-19 19:05:54
- Reporting Period:
- 2024-01-18
- Accepted Time:
- 2024-01-19 19:05:54
- SEC Url:
- Form 4 Filing
Issuer
| Cik | Name | Symbol | Sector (SIC) | IRS No |
|---|---|---|---|---|
| 1576885 | Acumen Pharmaceuticals Inc. | ABOS | Biological Products, (No Disgnostic Substances) (2836) | 364108129 |
Insiders
| Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
|---|---|---|---|---|---|---|---|
| 1790214 | Matt Zuga | C/O Acumen Pharmaceuticals, Inc. 427 Park Street Charlottesville VA 22902 | Cfo & Chief Business Officer | No | Yes | No | No |
Reported Non-Derivative Transactions
| Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|---|---|---|---|---|---|
| Common Stock | Disposition | 2024-01-18 | 4,242 | $3.71 | 211,445 | No | 4 | S | Direct |
| Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
|---|---|---|---|---|
| No | 4 | S | Direct |
Footnotes
- Represents the number of shares sold by the Reporting Person through an automatic "sell to cover" transaction to satisfy tax withholding obligations in connection with the vesting of restricted stock units ("RSUs") pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on September 13, 2023.
Billionaire Hedge Funds
